Shareholders Equity (Quarterly) Chart

View Shareholders Equity (Quarterly) for BGMS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shareholders Equity (Quarterly) Chart
Start Trial

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2003. Start Trial.
Date Value
June 30, 2026 7.16M
March 31, 2026 6.76M
December 31, 2025 6.842M
September 30, 2025 7.096M
June 30, 2025 3.631M
March 31, 2025 3.062M
December 31, 2024 -2.174M
September 30, 2024 -0.97M
June 30, 2024 0.999M
March 31, 2024 -2.206M
December 31, 2023 0.607M
September 30, 2023 4.297M
June 30, 2023 9.63M
March 31, 2023 14.64M
December 31, 2022 20.43M
September 30, 2022 26.56M
June 30, 2022 30.21M
March 31, 2022 33.41M
December 31, 2021 37.26M
September 30, 2021 41.36M
June 30, 2021 43.22M
March 31, 2021 48.05M
December 31, 2020 33.26M
September 30, 2020 24.44M
June 30, 2020 26.58M
Date Value
March 31, 2020 10.39M
December 31, 2019 11.70M
September 30, 2019 13.85M
June 30, 2019 15.73M
March 31, 2019 17.56M
December 31, 2018 15.27M
September 30, 2018 16.60M
June 30, 2018 18.62M
March 31, 2018 20.40M
December 31, 2017 21.77M
September 30, 2017 23.46M
June 30, 2017 11.64M
March 31, 2017 12.82M
December 31, 2016 14.27M
September 30, 2016 16.94M
June 30, 2016 13.16M
March 31, 2016 15.90M
December 31, 2015 18.84M
September 30, 2015 21.60M
June 30, 2015 24.10M
March 31, 2015 27.03M
December 31, 2014 21.69M
September 30, 2014 24.64M
June 30, 2014 29.59M
March 31, 2014 24.98M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
Supermax Corp. Bhd. 945.14M
YD Bio Ltd. -16.05M
ALPS Group, Inc. -11.23M
Cencora, Inc. 3.051B
ACADIA Pharmaceuticals, Inc. 1.307B

Shareholders Equity (Quarterly) Related Metrics